Marquis® Paste (Rx) - 4 ct box
Note: Availability varies. Contact us to inquire status.
First FDA-approved treatment for equine protozoal myeloencephalitis (EPM). Is indicated as an aid in reducing the clinical severity of Equine Protozoal Myeloencephalitis (EPM) caused by Sarcocystis neurona in horses; it is expected that approximately two horses out of three will respond favourably to treatment. Four 127 g syringes/box.
This product is not eligible for any discounts.